Without immediate action, humanity will face a potentially disastrous escalation in resistance in fungal disease, a renowned ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

Crystal Flush’s Super-40 Probiotic, a blend of six potent strains totaling 40 billion CFUs, enhances gut health and aims to ...

F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...

Read this Kerassentials review to find out if this formula effectively supports nail health by addressing fungal infections.

Kerassentials is a novel formula designed to combat antifungal resistance and alleviate toenail itching. The formula h ...

A group of scientists at the Department of Energy's Oak Ridge National Laboratory have conducted neutron scattering research ...

Antimicrobial Resistance occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to ...

U.K.-based biotechnology company F2G has raised $100 million to complete late-stage testing of a new kind of antifungal ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...